Form 4: Stryker Corp. CFO Exercises Stock Options and Sells Shares

Stryker Corporation's Chief Financial Officer, Glenn S. Boehnlein, exercised stock options and sold shares on November 18, 2024.

Summary

• Glenn S. Boehnlein, the VP and Chief Financial Officer of Stryker Corp, executed transactions involving company stock on November 18, 2024.
• He exercised employee stock options to acquire 4,500 shares of common stock at a price of $122.51 per share.
• Following the exercise of options, Mr. Boehnlein sold 2,979 shares of common stock at a price of $390.08 per share.
• After these transactions, Mr. Boehnlein directly owns 4,373 shares of common stock and indirectly owns 1,554 shares through a 401K.
• He also holds 11,315 derivative securities in the form of employee stock options.

Sentiment

Score: 5

Explanation: The document is a neutral report of stock transactions by an executive, with no indication of positive or negative sentiment.

Industry Context

This is a routine filing related to insider transactions and is common for executives who hold stock options in publicly traded companies. It does not indicate any specific trend in the medical device industry.

Comparison to Industry Standards

• Executive stock option exercises and sales are a common practice across publicly traded companies, including Stryker's competitors such as Medtronic (MDT), Johnson & Johnson (JNJ), and Zimmer Biomet (ZBH).
• The timing and volume of these transactions are often influenced by personal financial planning and company vesting schedules.
• The reported prices are consistent with the market price of Stryker stock at the time of the transactions.

Stakeholder Impact

• The transactions have a minimal impact on shareholders as they are routine and do not indicate a change in the company's fundamentals.

Key Dates

Keywords

Stryker, Stock Options, SEC Form 4, Insider Trading, Glenn S. Boehnlein, Chief Financial Officer, Equity Securities